Is CBD Legal in Taiwan?
May 29, 2026
CBD is restricted in Taiwan as a pharmaceutical-only ingredient. Consumer CBD is banned; only TFDA-approved Epidiolex is available by prescription.
CBD is restricted in Taiwan as a pharmaceutical-only ingredient. Consumer CBD is banned; only TFDA-approved Epidiolex is available by prescription.
CBD in Taiwan is restricted and treated as a pharmaceutical-only ingredient under the Pharmaceutical Affairs Act (藥事法). The Taiwan Food and Drug Administration (TFDA) has consistently held that cannabidiol products — regardless of THC content — must be registered as medicines and dispensed by prescription. Consumer CBD oils, gummies, cosmetics, and supplements imported from the United States or Europe are not lawful for retail sale and have been seized at customs.
The TFDA approved Epidiolex (cannabidiol) for refractory epilepsy in 2020 via the special medical purpose pathway, and individual patients may apply for compassionate-use import under prescription. Recreational and wellness CBD products remain prohibited. The TFDA has issued repeated advisories targeting online CBD sales and cross-border e-commerce, with fines under the Pharmaceutical Affairs Act reaching NT$5 million.
This page is for informational purposes only and does not constitute legal advice. Verify current law with qualified counsel before making compliance decisions.
Restricted
Taiwan Food and Drug Administration (TFDA)
0% — pharmaceutical-grade CBD only
Pharmaceutical Affairs Act (藥事法); TFDA scheduling notices
Consumer CBD imports are prohibited and routinely seized at customs. Pharmaceutical CBD products such as Epidiolex may be imported by patients under TFDA compassionate-use authorisation with a physician's prescription.
